arrow
K

Kyung Sik Park

university of ulsan
H指数:36
被引数:4,375

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Phase 2, Multi-Center, Randomized, Double-Blind, Parallel-Group Trial to Evaluate the Efficacy and Safety of CKD-495 in Patients With Acute and Chronic Gastritis

一项评估CKD-495在急性及慢性胃炎患者中有效性和安全性的多中心、随机、双盲、平行分组II期临床试验

2025-04-100
OA
Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis

评估fexuprazan与埃索美拉唑在糜烂性食管炎中的疗效和安全性的随机对照试验

2022-11-2824
OAAI
A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease

一项随机、双盲、主动对照、非劣效、多中心4期研究,旨在评估埃索美拉唑/碳酸氢钠20/800 mg治疗非糜烂性胃食管反流病的疗效和安全性

2022-06-223
OAAI
2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease
2021-10-3081
OAAI
Efficacy and Safety of DWJ1252 Compared With Gasmotin in the Treatment of Functional Dyspepsia: A Multicenter, Randomized, Double-blind, Active-controlled Study
2021-01-304
OAAI
2019 Seoul Consensus on Esophageal Achalasia Guidelines
2020-04-3072
OAAI
Randomised phase 3 trial: tegoprazan, a novel potassium-competitive acid blocker, vs. esomeprazole in patients with erosive oesophagitis
2019-03-0677
OAAI